Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

856
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
856
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

606
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
606
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

542
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
542
Angina IV: Management01:26

Angina IV: Management

230
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
230

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic review of cardiovascular care delivery across health systems in the Asia-Pacific: a regional roadmap for strengthening cardiovascular care.

The Lancet regional health. Western Pacific·2026
Same author

Design and rationale of the pERSonalized cardIovascuLar dIsease prEvention, treatmeNt, and CarE (RESILIENCE) study.

Contemporary clinical trials·2026
Same author

CETP Inhibitors: Back With a New Target.

Circulation research·2026
Same author

Evaluation of Polygenic Scores and CT Imaging in Risk Factor Modification in Patients With Diabetes: Rationale and Design of the VOLTAIRE Study.

Clinical cardiology·2026
Same author

Obicetrapib and lipoprotein(a) levels in patients at high cardiovascular risk: a pooled analysis of trials.

European heart journal·2026
Same author

Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics.

Atherosclerosis·2026
Same journal

June 2026 Clinical challenge.

Australian journal of general practice·2026
Same journal

The Australian guide to living well with endometriosis.

Australian journal of general practice·2026
Same journal

Artificial intelligence-assisted mental healthcare in general practice: Benefits, risks and future possibilities.

Australian journal of general practice·2026
Same journal

The Medical Certificate of Cause of Death: Special situations and considerations.

Australian journal of general practice·2026
Same journal

Jumping in: Research skills development in general practice training, and incentives, barriers and enablers for novice GP researcher journeys.

Australian journal of general practice·2026
Same journal

General practitioner confidence with adolescent health: Baseline findings from a randomised controlled trial in general practice.

Australian journal of general practice·2026
See all related articles

Related Experiment Video

Updated: Jan 12, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.7K

Hypertriglyceridaemia: A practical approach for primary care.

Tom Brett1, Gerald F Watts2, Nick Sr Lan3

  • 1MBBS (Hons), MClinUS, MClinRes (Dist), MSc, FRACP, Cardiologist, Department of Cardiology, Fiona Stanley Hospital, Perth, WA; Clinical Senior Lecturer, Medical School, The University of Western Australia, Perth, WA.

Australian Journal of General Practice
|November 4, 2025
PubMed
Summary
This summary is machine-generated.

Managing hypertriglyceridaemia is crucial for preventing cardiovascular disease and pancreatitis. General practitioners should address secondary causes, promote lifestyle changes, and consider statins or icosapent ethyl for effective triglyceride management.

More Related Videos

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

470
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

895

Related Experiment Videos

Last Updated: Jan 12, 2026

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.7K
Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

470
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

895

Area of Science:

  • Cardiology
  • Endocrinology
  • General Practice

Background:

  • Hypertriglyceridaemia is a common clinical finding.
  • It significantly increases the risk of cardiovascular disease and acute pancreatitis.
  • General practitioners are key in managing this condition to prevent complications.

Purpose of the Study:

  • To present a current management strategy for hypertriglyceridaemia.
  • Focuses on application within Australian primary care settings.

Main Methods:

  • Identify and manage secondary causes of hypertriglyceridaemia.
  • Implement lifestyle modifications (diet, exercise, weight, alcohol).
  • Prescribe statins based on cardiovascular risk; consider icosapent ethyl for specific patient groups.

Main Results:

  • Lifestyle changes are fundamental for triglyceride reduction.
  • Statins can lower triglyceride levels and cardiovascular risk.
  • Icosapent ethyl is recommended for cardiovascular risk reduction in specific patients.
  • Intensive management is advised for severe hypertriglyceridaemia to prevent pancreatitis.

Conclusions:

  • A multi-faceted approach involving lifestyle, pharmacotherapy, and risk assessment is essential.
  • Early identification and management of secondary causes are critical.
  • Specialist referral is indicated for severe or suspected genetic cases.